Omega-3 and 6 Fatty Acids Omega-3

Synonyms

Omega Check

Allscripts (AEHR) Order Name

Omega-3 and 6 Fatty Acids

Sunrise Clinical Manager (SCM) Order Name

Omega-3 and 6 Fatty Acids

Clinical Info

Clinical Significance 1. Baseline and monitoring of individuals with known CVD (acute and chronic) to determine Rx and compliance. 2. Identify patients with known CVD risk with low omega-3 levels who may be candidates for supplementation/therapy. 3. Monitor patients on omega-3 supplementation/therapy to determine efficacy of treatment. 4. Potential role in risk reduction for non-CVD outcomes-aged related macular degeneration, RA, cancer, etc. (early data).

Specimen Type

Container

Lavender Top Tube

Collection Instructions

Container/Tube: Lavender EDTA tube
Specimen: 2 mL EDTA Plasma (0.6 mL min)
Transport Temperature: Refrigerated Plasma
 
 

Transport Instructions

Refrigerated Plasma

Specimen Stability

7 Days Room Temperature
14 Days Refrigerated
35 Days Frozen

Methodology

Chromatography/Mass Spectrometry
 
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.

Days Performed

TAT: 4-5 Days

Performing Laboratory

Quest Diagnostics' Nichols Institute, Inc. - Chantilly

CPT

82542

PDM

1759536, LAB65242497

Result Interpretation

 

Omega-3 (EPA+DHA) Index 1.4-4.9 %
Risk:  
Index <2.2: High
Index 2.2-3.2: Moderate
Index >3.2: Optimal
Omega-6/Omega-3 Ratio 5.7-21.3
EPA/Arachidonic Acid Ratio ≤0.2
Arachidonic Acid 5.2-12.9%
EPA 0.2-1.5 %
DHA 1.2-3.9 %

 

Forms

edit